[Opinion] Should the 90% CI for GMR be required to encompass 1 [RSABE / ABEL]

posted by jag009  – NJ, 2018-03-29 23:22 (2579 d 04:24 ago) – Posting: # 18621
Views: 11,409

If I recall (or I am imagining things), FDA published a paper about NTI drug BE assessment (Helmut, help! Am I hallucinating again?)

Anyhow, Have you looked at this FDA slide presentation before?

NTI

John

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,674 registered users;
24 visitors (0 registered, 24 guests [including 6 identified bots]).
Forum time: 03:47 CEST (Europe/Vienna)

The combination of some data and an aching desire
for an answer does not ensure that a reasonable answer
can be extracted from a given body of data.    John W. Tukey

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5